Levomenthol
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB00825 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 27 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | nephrogenic syndrome of inappropriate antidiuresis | KG + DL |
| 2 | pulmonary hypertension | KG + DL |
| 3 | kyphoscoliotic heart disease | KG + DL |
| 4 | primary hereditary glaucoma | KG + DL |
| 5 | open-angle glaucoma | KG + DL |
| 6 | hypertrichosis (disease) | KG + DL |
| 7 | migraine disorder | KG + DL |
| 8 | malformation syndrome with odontal and/or periodontal component | KG + DL |
| 9 | migraine with brainstem aura | KG + DL |
| 10 | Ambras type hypertrichosis universalis congenita | KG + DL |
| 11 | syndrome with a Dandy-Walker malformation as major feature | KG + DL |
| 12 | isolated genetic hair shaft abnormality | KG + DL |
| 13 | alopecia | KG + DL |
| 14 | cor pulmonale | KG + DL |
| 15 | hypotrichosis simplex of the scalp | KG + DL |
| 16 | congenital hypotrichosis milia | KG + DL |
| 17 | Prinzmetal angina | KG + DL |
| 18 | pulmonary hypertension, primary, autosomal recessive | KG + DL |
| 19 | obsolete patella aplasia, coxa vara, and tarsal synostosis | KG + DL |
| 20 | Raynaud disease | KG + DL |
| 21 | subarachnoid hemorrhage (disease) | KG + DL |
| 22 | benign prostatic hyperplasia (disease) | KG + DL |
| 23 | diffuse alopecia areata | KG + DL |
| 24 | nephrogenic diabetes insipidus | KG + DL |
| 25 | headache disorder | KG + DL |
| 26 | familial clubfoot due to 17q23.1q23.2 microduplication | KG + DL |
| 27 | chromosome 17q23.1-q23.2 deletion syndrome | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.